Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Moodys
Medtronic
Merck
Harvard Business School

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NOXAFIL

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for NOXAFIL

Average Pharmacy Cost for NOXAFIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NOXAFIL DR 100 MG TABLET 00085-4324-02 66.27650 EACH 2019-07-17
NOXAFIL 40 MG/ML SUSPENSION 00085-1328-01 13.36695 ML 2019-01-04
NOXAFIL DR 100 MG TABLET 00085-4324-02 65.86858 EACH 2019-01-04
NOXAFIL DR 100 MG TABLET 00085-4324-02 62.73497 EACH 2018-11-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NOXAFIL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NOXAFIL 300MG Merck Sharp & Dohme Corporation 00085-4331-01 1 315.98 315.98000 EACH 2019-01-01 - 2023-08-31 Big4
NOXAFIL 200MG/5ML ORAL SUSP Merck Sharp & Dohme Corporation 00085-1328-01 105ML 853.47 8.12829 ML 2018-09-01 - 2023-08-31 Big4
NOXAFIL 300MG Merck Sharp & Dohme Corporation 00085-4331-01 1 521.50 521.50000 EACH 2019-01-01 - 2023-08-31 FSS
NOXAFIL 200MG/5ML ORAL SUSP Merck Sharp & Dohme Corporation 00085-1328-01 105ML 1171.47 11.15686 ML 2018-09-01 - 2023-08-31 FSS
NOXAFIL 200MG/5ML ORAL SUSP Merck Sharp & Dohme Corporation 00085-1328-01 105ML 981.97 9.35210 ML 2019-01-01 - 2023-08-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Merck
Harvard Business School
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.